InKemia IUCT Group will launch a new €10-million fund for start-ups and spin-offs in the health and life sciences. The fund, called Inkemia Fond-ICO Global, is endowed with a total of eight million euros: five from the Fond-ICO contest the company won recently and three from smaller investors.

Between the participating companies and spin-offs themselves, InKemia has 14 high-tech businesses in various sectors of the life sciences. Two of these emerging companies are based in the US and the UK, as one of the aims of this group traded on the Alternative Investment Market (MAB) is to continue growing through internationalisation.